Bruker Corp- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Bruker Corp 公司

Bruker Corporation is a developer, manufacturer and distributor of high-performance scientific instruments and analytical and diagnostic. Its segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research. BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, and fluorescence optical microscopy instruments. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and energy physics research.

Bruker Corp简介



公司代码BRKR

公司名称Bruker Corp

上市日期Aug 04, 2000

CEOPrause (Burkhard A)

员工数量11396

证券类型Ordinary Share

年结日Aug 04

公司地址40 Manning Rd

城市BILLERICA

上市交易所NASDAQ OMX - NASDAQ BASIC

国家United States of America

邮编01821-3915

电话19786633660

网址https://www.bruker.com/

公司代码BRKR

上市日期Aug 04, 2000

CEOPrause (Burkhard A)

Bruker Corp公司高管



名称

名称/职务

职务

持股

持股变动

Dr. Frank H. Laukien, Ph.D.

Chairman of the Board, President, Chief Executive Officer

40.41M

-0.02%

Mr. Richard A. Packer

Independent Director

89.17K

-1.37%

Dr. Mark Robert Munch, Ph.D.

Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division

84.15K

-13.33%

Mr. Gerald N. Herman

Chief Financial Officer, Executive Vice President

56.19K

-24.79%

Mr. John A. Ornell, CPA

Independent Director

35.21K

-3.47%

Dr. Falko Busse, Ph.D.

President - Bruker BioSpin Group

30.94K

-15.02%

Dr. Hermann Fritz Requardt, Ph.D.

Independent Director

26.45K

-4.62%

Ms. Adelene Q. Perkins

Independent Director

24.62K

-4.96%

Dr. Cynthia M. Friend, Ph.D.

Independent Director

18.02K

-6.78%

Ms. Bonnie H. Anderson

Independent Director

13.33K

-9.17%

名称

名称/职务

职务

持股

持股变动

Dr. Frank H. Laukien, Ph.D.

Chairman of the Board, President, Chief Executive Officer

40.41M

-0.02%

Mr. Richard A. Packer

Independent Director

89.17K

-1.37%

Dr. Mark Robert Munch, Ph.D.

Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division

84.15K

-13.33%

Mr. Gerald N. Herman

Chief Financial Officer, Executive Vice President

56.19K

-24.79%

Mr. John A. Ornell, CPA

Independent Director

35.21K

-3.47%

Dr. Falko Busse, Ph.D.

President - Bruker BioSpin Group

30.94K

-15.02%

收入明细

单位: USD更新时间: 4月6日周一

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Product

2.77B

80.50%

Product And Service Other

670.10M

19.50%

Service and other revenue

670.10M

19.50%

地区USD

名称

营收

占比

Rest of Europe

950.20M

27.65%

United States

891.30M

25.94%

Rest of Asia Pacific

552.60M

16.08%

China

475.80M

13.85%

Germany

297.00M

8.64%

Other

269.60M

7.85%

业务

地区

业务USD

名称

营收

占比

Product

2.77B

80.50%

Product And Service Other

670.10M

19.50%

Service and other revenue

670.10M

19.50%

股东统计

更新时间: 5月11日周一

持股股东

股东类型

持股股东

占比

Laukien (Frank H)

26.54%

Orbis Investment Management Ltd.

10.60%

Fidelity Management & Research Company LLC

8.45%

Pallas Capital Advisors LLC

6.23%

BlackRock Institutional Trust Company, N.A.

6.19%

其他

41.99%

持股股东

占比

Laukien (Frank H)

26.54%

Orbis Investment Management Ltd.

10.60%

Fidelity Management & Research Company LLC

8.45%

Pallas Capital Advisors LLC

6.23%

BlackRock Institutional Trust Company, N.A.

6.19%

其他

41.99%

股东类型

持股股东

占比

Investment Advisor

50.84%

Investment Advisor/Hedge Fund

27.99%

Individual Investor

26.97%

Hedge Fund

8.83%

Research Firm

1.99%

Pension Fund

1.24%

Private Equity

0.37%

Bank and Trust

0.35%

Insurance Company

0.21%

机构持股



更新时间: 4月5日周日

报告期

机构数

持股数

持股占比

持股变动

2026Q1

929

139.65M

91.74%

-14.82M

2025Q4

887

137.27M

94.12%

+111.45K

2025Q3

908

137.16M

94.45%

+8.73M

2025Q2

904

127.18M

89.58%

+1.13M

2025Q1

886

125.13M

85.85%

-5.11M

2024Q4

855

125.47M

82.99%

+4.02M

2024Q3

812

120.93M

80.76%

+2.25M

2024Q2

782

118.65M

76.64%

+5.15M

2024Q1

766

113.09M

82.81%

-916.64K

2023Q4

748

112.27M

83.16%

-472.55K

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

Laukien (Frank H)

40.41M

26.55%

+31.93K

+0.08%

Aug 15, 2025

Orbis Investment Management Ltd.

16.13M

10.6%

+1.22M

+8.21%

Feb 28, 2026

Fidelity Management & Research Company LLC

12.87M

8.45%

+1.44M

+12.65%

Dec 31, 2025

Pallas Capital Advisors LLC

9.48M

6.23%

+114.00

+0.00%

Dec 31, 2025

BlackRock Institutional Trust Company, N.A.

9.42M

6.19%

+199.52K

+2.16%

Dec 31, 2025

State Street Investment Management (US)

3.83M

2.52%

+91.71K

+2.45%

Dec 31, 2025

T. Rowe Price Investment Management, Inc.

3.19M

2.1%

-3.19M

-50.01%

Dec 31, 2025

Sculptor Capital Management, Inc

3.00M

1.97%

-74.80K

-2.43%

Dec 31, 2025

持股ETF



更新时间: 12月6日周六

机构名称

占比

First Trust NYSE Arca Biotechnology Index Fund

3.71%

ProShares Nanotechnology ETF

3.34%

State Street SPDR S&P Kensho Future Security ETF

1.27%

Ballast Small/Mid Cap ETF

1.13%

AB Disruptors ETF

0.63%

Invesco NASDAQ Future Gen 200 ETF

0.61%

State Street SPDR S&P Kensho New Econ Comp ETF

0.57%

iShares Health Innovation Active ETF

0.4%

iShares Biotechnology ETF

0.36%

JPMorgan Active Small Cap Value ETF

0.31%

First Trust NYSE Arca Biotechnology Index Fund

占比3.71%

ProShares Nanotechnology ETF

占比3.34%

State Street SPDR S&P Kensho Future Security ETF

占比1.27%

Ballast Small/Mid Cap ETF

占比1.13%

AB Disruptors ETF

占比0.63%

Invesco NASDAQ Future Gen 200 ETF

占比0.61%

State Street SPDR S&P Kensho New Econ Comp ETF

占比0.57%

iShares Health Innovation Active ETF

占比0.4%

iShares Biotechnology ETF

占比0.36%

JPMorgan Active Small Cap Value ETF

占比0.31%

分红派息



近5年累计派现 113.60M 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

Mar 04, 2026

BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Apr 07, 2026 going ex on Mar 23, 2026

Mar 23, 2026

Apr 07, 2026

Mar 23, 2026

Nov 04, 2025

BRKR.NB Final Cash Dividend of gross USD 0.05 paid on Jan 02, 2026 going ex on Dec 08, 2025

Dec 08, 2025

Jan 02, 2026

Dec 08, 2025

Aug 12, 2025

BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Oct 03, 2025 going ex on Sep 23, 2025

Sep 23, 2025

Oct 03, 2025

Sep 23, 2025

May 15, 2025

BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Jun 27, 2025 going ex on Jun 16, 2025

Jun 16, 2025

Jun 27, 2025

Jun 16, 2025

Feb 21, 2025

BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Mar 28, 2025 going ex on Mar 17, 2025

Mar 17, 2025

Mar 28, 2025

Mar 17, 2025

Nov 18, 2024

BRKR.NB Final Cash Dividend of gross USD 0.05 paid on Dec 16, 2024 going ex on Dec 02, 2024

Dec 02, 2024

Dec 16, 2024

Dec 02, 2024

Aug 14, 2024

BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Sep 16, 2024 going ex on Aug 30, 2024

Sep 02, 2024

Sep 16, 2024

Aug 30, 2024

May 15, 2024

BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Jun 17, 2024 going ex on Jun 03, 2024

Jun 03, 2024

Jun 17, 2024

Jun 03, 2024

Feb 16, 2024

BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Mar 15, 2024 going ex on Feb 29, 2024

Mar 01, 2024

Mar 15, 2024

Feb 29, 2024

Nov 20, 2023

BRKR.NB Final Cash Dividend of gross USD 0.05 paid on Dec 15, 2023 going ex on Nov 30, 2023

Dec 01, 2023

Dec 15, 2023

Nov 30, 2023

拆合股



公告日期

除权除息日

类型

比率

暂无数据

公告日期

除权除息日

类型

比率

暂无数据